This transcriptional signature mirrors the stabilization of circulating IL-1β observed in HD patients receiving jaboticaba peel supplementation, suggesting that ellagic acid may exert its effects by attenuating NF-κB-dependent cytokine signaling and modulating NLRP3 inflammasome activation. Here, NLRP3 is linked to Huntington disease.